These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33826485)

  • 1. Vernal Keratoconjunctivitis as the Only Clinical Manifestation of HIV Infection.
    Farias RJM; Gama MEA; Mendes R; Lobão NTM; Barbosa de Sousa L
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1530-1532. PubMed ID: 33826485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
    Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
    Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.
    Ali A; Bielory L; Dotchin S; Hamel P; Strube YNJ; Koo EB
    Surv Ophthalmol; 2024; 69(2):265-278. PubMed ID: 37890678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of corticosteroid eye drops for allergic eye diseases in children].
    Csorba A; Soproni A; Maneschg O; Nagy ZZ; Szamosi A
    Orv Hetil; 2019 Mar; 160(9):329-337. PubMed ID: 30798620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.
    Lambiase A; Minchiotti S; Leonardi A; Secchi AG; Rolando M; Calabria G; Orsoni J; Zola E; Ferreri G; Aragona P; Reibaldi A; Chisari G; Bonini S
    Ophthalmic Epidemiol; 2009; 16(1):38-41. PubMed ID: 19191180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.